Brief: Biogaia: MetaboGen Reached New Crucial Milestone In Its Development Of Novel Probiotic Products

Biogaia AB

12/02/2021 07:10

Feb 12 (Reuters) - Biogaia AB  BIOGb.ST :
    * METABOGEN HAS REACHED A NEW CRUCIAL MILESTONE IN ITS
DEVELOPMENT
OF NOVEL PROBIOTIC PRODUCTS
    * METABOGEN AIMS AT DEVELOPING NEXT GENERATION PROBIOTIC
PRODUCTS
FOCUSING ON METABOLIC CONDITIONS WITH SPECIAL EMPHASIS ON
DIABETES AND RELATED DISEASES.
    * METABOGEN HAS NOW RECEIVED APPROVAL FROM ETHICS COMMITTEE
TO
PROCEED INTO ITS NEXT CLINICAL STUDY, TARGETING A PRE-DIABETIC
POPULATION.

Source text for Eikon:  ID:nWkrc43ZgL 
Further company coverage:  BIOGb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))